Lybrido for Female Sexual Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2013

Conditions
Hypoactive Sexual Desire Disorder
Interventions
DRUG

Placebo

Solid Oral Dosage. Maximum every other day (on an as needed basis)

DRUG

Sildenafil

Solid Oral Dosage. Maximum every other day (on an as needed basis)

DRUG

Testosterone

Solid Oral Dosage. Maximum every other day (on an as needed basis)

Trial Locations (14)

10577

Michael A. Werner, MD PC, Purchase

19114

Philadelphia Clinical Research, Philadelphia

20037

The Center for Vulvovaginal Disorders, Washington D.C.

21401

Annapolis Sexual Wellness Center, Annapolis

21666

Maryland Prime Care Physicians, Stevensville

22104

Center for Sexual Medicine at Sheppard Pratt, Townson

32806

Compass Research, Orlando

33143

Miami Research Associates, South Miami

33161

Segal Institute Women's Health Clinic, North Miami

33409

Comprehensive Clinical Trials, LLC, West Palm Beach

34203

Meridien Research, St. Petersburg

34601

Meridien Research, Brooksville

92120

San Diego Sexual Medicine, San Diego

08536

Women's Health Research Center, Plainsboro

Sponsors
All Listed Sponsors
lead

Emotional Brain NY Inc.

INDUSTRY